BIZCHINA> Direct Investment
|
Eli Lilly launched new R&D center
(China Daily)
Updated: 2008-10-16 16:17 Pharmaceutical firm Eli Lilly and Company announced on Wednesday it has opened an R&D headquarters in China. The Shanghai office will house a scientific management and venture investment team. "China, with its vast supply of scientific talents, vibrant entrepreneurs and superb infrastructure, will become a fertile ground to define the winning model of future drug R&D," said Robert Armstrong, vice-president of Lilly's global external research and development. (For more biz stories, please visit Industries)
|